Everything we've seen

1. ·Nov 15, 11:30 AMstreamnews

   Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

   Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

2. ·Nov 15, 11:15 AMstreamnews

   Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

   Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

3. ·Nov 15, 11:00 AMstreamnews

   Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

   Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

4. ·Nov 15, 10:45 AMstreamnews

   Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

   Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

5. ·Nov 15, 10:30 AMstreamnews

   Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

   Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

6. ·Nov 15, 10:15 AMstreamnews

   Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

   Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

7. ·Nov 15, 10:00 AMstreamnews

   Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

   Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

8. ·Nov 15, 9:45 AMstreamnews

   Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

   Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

9. ·Nov 15, 9:30 AMstreamnews

   Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

   Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

10. ·Nov 15, 9:15 AMstreamnews

    Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

    Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

11. ·Nov 15, 9:00 AMstreamnews

    Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

    Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

12. ·Nov 15, 8:45 AMstreamnews

    Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

    Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

13. ·Nov 15, 8:30 AMstreamnews

    Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

    Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

14. ·Nov 15, 8:15 AMstreamnews

    Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

    Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

15. ·Nov 15, 8:00 AMstreamnews

    Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

    Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

16. ·Nov 15, 7:45 AMstreamnews

    Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

    Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

17. ·Nov 15, 7:30 AMstreamnews

    Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

    Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

18. ·Nov 15, 7:15 AMstreamnews

    Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

    Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

19. ·Nov 15, 7:00 AMstreamnews

    Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

    Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

20. ·Nov 15, 6:45 AMstreamnews

    Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

    Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

21. ·Nov 15, 6:30 AMstreamnews

    Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

    Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

22. ·Nov 15, 6:15 AMstreamnews

    Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

    Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

23. ·Nov 15, 6:01 AMstreamnews

    Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

    Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

24. ·Nov 15, 5:45 AMstreamnews

    Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

    Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

25. ·Nov 15, 5:30 AMstreamnews

    Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

    Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

26. ❖Nov 13, 6:02 PMnewsvia finnhub

    Amgen vs. Vertex Pharmaceuticals: Which Healthcare Stock Is a Better Buy for 2027?

    Amgen trades at a lower forward P/E than Vertex, but Vertex's near-zero debt and cystic fibrosis dominance make the trade-off harder to call.

27. ❖Nov 13, 8:30 AMnewsvia finnhub

    Wall Street Analysts Think Cardinal (CAH) Is a Good Investment: Is It?

    Based on the average brokerage recommendation (ABR), Cardinal (CAH) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

28. ❖Nov 12, 9:55 AMnewsvia finnhub

    Sterilization Monitoring Technologies - Global Strategic Business Report 2026: Secure Share of the $1 Billion Market by 2032 | Features Competitive Intelligence on 3M, Steris, Getinge, Cardinal Health and Mesa Laboratories

    Smart, wireless and cloud-based monitoring improves accuracy, automates compliance, reduces errors and streamlines sterilization workflows across healthcare settingsDublin, Nov. 12, 2026 (GLOBE NEWSWIRE) -- "Sterilization Monitoring Technologies - Global Strategic Business Report 2026" has been added to ResearchAndMarkets.com's offering. The global sterilization monitoring technologies market was valued at US$691.5 million in 2025 and is projected to reach US$1 billion by 2032, expanding at a co

29. ❖Nov 12, 4:59 AMnewsvia finnhub

    Argus Research Maintains Buy on Cardinal Health, Raises Price Target to $309

    Argus Research analyst David Toung maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $264 to $309.

30. ❖Nov 12, 12:13 AMnewsvia finnhub

    Cardinal Health (CAH) Stock Could Be Pricey Following Raised Earnings Guidance

    Cardinal Health has turned into one of the stronger long term performers in the healthcare distribution space. This puts fresh attention on whether the current share price lines up with what its earnings can support. After such a strong run, the key issue for you is whether the recent optimism baked into the stock is covered by the profit engine underneath. Over the past 5 years, Cardinal Health has delivered a very large cumulative return. This now makes the earnings power of the business...

31. ❖Nov 11, 4:30 PMnewsvia finnhub

    Cardinal Health Board of Directors Approves Quarterly Dividend

    Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5158 per share, out of the Company's capital surplus. The dividend will be payable on January 15, 2027 to shareholders of record at the close of business on January 4, 2027.

32. ❖Nov 11, 11:08 AMnewsvia finnhub

    Is Jim Cramer-backed Cardinal Health’s Dividend Safe?

    We just published the list of Jim Cramer’s Top 10 Dividend Stocks for Safe, Consistent Returns, and Cardinal Health, Inc. (NYSE:CAH) ranked 9th on this list. From 2000 through 2009, dividends earned S&P 500 investors an annualized 1.8%, according to Hartford Funds. Even with those payments, the index posted a negative total return for the […]

33. ❖Nov 11, 11:00 AMnewsvia finnhub

    Here's Why Cardinal Health (CAH) is a Great Momentum Stock to Buy

    Does Cardinal Health (CAH) have what it takes to be a top stock pick for momentum investors? Let's find out.

34. ❖Nov 11, 1:10 AMnewsvia finnhub

    Zacks.com featured highlights include Stride, Ralph Lauren, Cardinal Health and Vertiv

    LRN, RL, CAH and VRT stand out for strong interest coverage ratios, supported by earnings growth projections and positive earnings surprises.

35. ❖Nov 10, 2:42 PMnewsvia finnhub

    Cardinal (CAH) is an Incredible Growth Stock: 3 Reasons Why

    Cardinal (CAH) could produce exceptional returns because of its solid growth attributes.

36. ❖Nov 10, 2:33 PMnewsvia finnhub

    If You Invested $100 In Cardinal Health Stock 5 Years Ago, You Would Have This Much Today

    Cardinal Health (NYSE:CAH) has outperformed the market over the past 5 years by 30.64% on an annualized basis producing an average annual return of 40.55%. Currently, Cardinal Health has a market capitalization of

37. ❖Nov 10, 12:45 PMnewsvia finnhub

    4 Stocks with Impressive Interest Coverage Ratios to Buy Now

    Stride, Ralph Lauren, Cardinal Health and Vertiv stand out for strong interest coverage ratios, earnings growth prospects and financial resilience.

38. ❖Nov 10, 8:11 AMnewsvia finnhub

    Can Cardinal Health Stock Repeat Its Last Five Years?

    For questions about this article or underlying research, email help@trefis.com.

39. ❖Nov 10, 7:33 AMnewsvia finnhub

    JP Morgan Maintains Neutral on Cardinal Health, Raises Price Target to $286

    JP Morgan analyst Lisa Gill maintains Cardinal Health (NYSE:CAH) with a Neutral and raises the price target from $260 to $286.

40. ❖Nov 10, 6:01 AMnewsvia finnhub

    CAH Q3 CY2026 deep dive: specialty growth and contract renewals drive guidance increase

    Healthcare distributor and services company Cardinal Health (NYSE:CAH) reported calendar Q3 2026 (fiscal Q1 2027) results topping the market’s revenue expectations, with sales up 5.5% year on year to $67.51 billion. Its non-GAAP profit of $3.26 per share was 10.9% above analysts’ consensus estimates.

41. ❖Nov 9, 8:40 AMnewsvia finnhub

    Should Value Investors Buy Cardinal Health (CAH) Stock?

    Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

42. ❖Nov 9, 8:40 AMnewsvia finnhub

    Are Medical Stocks Lagging Cardinal Health (CAH) This Year?

    Here is how Cardinal Health (CAH) and Addus HomeCare (ADUS) have performed compared to their sector so far this year.

43. ❖Nov 9, 6:56 AMnewsvia finnhub

    TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $304

    TD Cowen analyst Charles Rhyee maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $280 to $304.

44. ❖Nov 9, 3:46 AMnewsvia finnhub

    Jim Cramer Praises The 'Number One Oil Company In The World'

    Jim Cramer discusses Okta, VF, Trinity Capital, JPMorgan, Ameriprise Financial, Cardinal Health, D-Wave, Chevron and Netflix.

45. ❖Nov 7, 11:14 AMnewsvia finnhub

    McKesson Q2 Earnings Call Highlights

    McKesson (NYSE:MCK) raised its fiscal 2027 adjusted earnings outlook after reporting higher second-quarter revenue and profit, supported by prescription volumes, specialty distribution and demand for medication access services. The company now expects adjusted earnings of $45.60 to $46.40 per dilut

46. ❖Nov 7, 12:35 AMnewsvia finnhub

    69 Dividend Champions Ranked By Quality Scores (November 2026)

    Explore 69 Dividend Champions ranked by quality, safety, and value.

47. ❖Nov 7, 12:14 AMnewsvia finnhub

    Cardinal Health Q1 Earnings Call Highlights

    Cardinal Health (NYSE:CAH) raised its fiscal 2027 earnings outlook after reporting double-digit profit growth in its pharmaceutical and specialty segment and its other growth businesses for the first quarter. The healthcare distributor now expects non-GAAP diluted earnings per share of $12.80 to $1

48. ▣Nov 6, 7:00 PMjournaltarget

    Agent 4 — Dip Buyer (Frozen) closed long 4 @ $271.72 (+$181.52)

    Target hit: close $271.72 ≥ target $258.30

49. ❖Nov 6, 6:26 PMnewsvia finnhub

    Is McKesson Stock Increasing Your Market Risk?

    For questions about this article or underlying research, email help@trefis.com.

50. ❖Nov 6, 9:10 AMnewsvia finnhub

    RBC Capital Maintains Outperform on Cardinal Health, Raises Price Target to $295

    RBC Capital analyst Ryan Halsted maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $276 to $295.

51. ❖Nov 6, 9:00 AMnewsvia finnhub

    CAH Q1 Earnings Call Highlights Raised Outlook and Specialty Growth

    Cardinal Health raises its fiscal 2027 earnings outlook as specialty growth, strong generics demand and customer renewals offset medical distribution pressures.

52. ❖Nov 6, 8:30 AMnewsvia finnhub

    Company News for Nov 6, 2026

    Companies in The News Are: CMI, CAH, APLD, SONY

53. ❖Nov 6, 5:39 AMnewsvia finnhub

    Evercore ISI Group Maintains Outperform on Cardinal Health, Raises Price Target to $320

    Evercore ISI Group analyst Elizabeth Anderson maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $270 to $320.

54. ❖Nov 6, 5:16 AMnewsvia finnhub

    Does Earnings Beat Change The Bull Case For Cardinal Health Stock (CAH)?

    Cardinal Health reported first quarter fiscal 2027 results for the period ended September 30, 2026, with sales of US$67.513b, net income of US$554m, and diluted EPS from continuing operations of US$2.38 compared with US$1.88 a year earlier. The company lifted its full year adjusted EPS guidance after outperformance in Pharmaceutical and Specialty Solutions, underlining management’s focus on higher value distribution and services across specialty, biopharma partnerships, and at home care. We...

55. ❖Nov 5, 6:18 PMnewsvia finnhub

    Cardinal Health Inc (CAH) (Q1 2027) Earnings Call Highlights: Record $1 Billion Operating ...

    Cardinal Health Inc (CAH) posted 5% revenue growth to $67.5 billion, lifted fiscal 2027 EPS guidance to $12.80--$13.00, and renewed its largest customer through 2032.

56. ❖Nov 5, 4:18 PMnewsvia finnhub

    Cardinal Health (CAH) Q1 2027 Earnings Call Transcript

    Record operating income and a raised profit outlook drove a strong quarter.

57. ❖Nov 5, 3:12 PMnewsvia finnhub

    Cardinal Health (CAH) Lifts Outlook As Earnings Beat Fuels Debate Over Fair Value

    Why Cardinal Health’s latest quarter matters for investors Cardinal Health (CAH) just turned in first quarter numbers that topped earnings and revenue expectations, lifted its full year 2027 adjusted EPS outlook, and finished a sizeable share buyback program. The catalyst goes beyond a headline beat. Stronger performance in the Pharmaceutical and Specialty Solutions segment, renewed distribution agreements with CVS Health, and management’s updated profit targets give investors fresh data on...

58. ❖Nov 5, 3:06 PMnewsvia finnhub

    S&P 500 Top Movers: Gainers and Losers in Nov. 5, 2026 Session

    S&P 500 top movers for Nov. 5, 2026: AppLovin led gainers at 30.24%, while SanDisk led losers at -17.67% in the US session.

59. ❖Nov 5, 1:07 PMnewsvia finnhub

    CAH Shares Post New Record, EW Stock Hits Over Three-Year High – What’s Driving Today’s Rally?

    Cardinal Health reported a 5% increase in Q1 revenue, beating Wall Street’s forecast, while analysts raised Edwards Lifesciences’ price target after a better-than-expected Q3 print.

60. ❖Nov 5, 12:55 PMnewsvia finnhub

    Becton Dickinson, Cardinal Health Beat Quarterly Views

    Becton Dickinson (BDX) and Cardinal Health (CAH) reported stronger-than-expected quarterly results o

61. ❖Nov 5, 12:36 PMnewsvia finnhub

    S&P 500 Top Movers: AppLovin Leads Today's Session With 29.19% Gain

    S&P 500 top movers for today's session: AppLovin led gainers with a 29.19% jump, while Sandisk, Bloom Energy, and Western Digital posted double-digit declines.

62. ❖Nov 5, 12:15 PMnewsvia finnhub

    Drug Wholesalers Go Three-For-Three In Earnings Beats, But Only Two Stocks Pop

    Drug distributors went three-for-three, with Cardinal Health putting up the last fall-quarter beat on Thursday, following the examples set by McKesson and Cencora.

63. ❖Nov 5, 12:14 PMnewsvia finnhub

    Cardinal Health Reports First Quarter Fiscal Year 2027 Results and Raises Outlook

64. ✓Nov 5, 12:01 PMdecisionacted

    Agent 7 — Day Trader — decide: buy

    CAH is up 2.81% on a clear fundamental catalyst: Q1 earnings beat on both EPS and revenue, with street-beating guidance raising the buy zone. Multiple confirming headlines across the session indicate sustained institutional interest rather than a single spike. The move has legs because guidance upgrades typically attract follow-on buying throughout the session as analysts revise and funds add exposure. With 225 minutes remaining there is ample time for continuation. The macro context (elevated DFF, 2.1σ above trend) is modestly neutral-to-negative for the broader market but CAH as a healthcare distributor is relatively insensitive to short-term rate noise — it is not in the sectors most reactive to DFF moves (banks, money-market funds). The absence of any reversal signal or fade pattern and the presence of a genuine fundamental re-rating event support continuation. Probability held at 0.63 rather than higher because a 2.81% gap on earnings is already a meaningful portion of the typical post-earnings day range, limiting incremental upside, and no volume data is available to confirm sustained institutional buying.

65. ❖Nov 5, 11:39 AMnewsvia finnhub

    What Just Happened To Medline Stock?

    For questions about this article or underlying research, email help@trefis.com.

66. ❖Nov 5, 11:25 AMnewsvia finnhub

    Amgen vs. Pfizer: Which Healthcare Stock Is a Better Buy for 2027?

    Amgen's growth engine and Pfizer's value appeal pull in opposite directions, and the valuation gap between them is wider than many expect.

67. ❖Nov 5, 11:16 AMnewsvia finnhub

    CAH Q1 Earnings & Revenues Beat Estimates on Pharma Strength

    Cardinal Health beats Q1 FY27 earnings and revenue estimates, fueled by pharmaceutical sales growth, and raises its full-year earnings outlook.

68. ❖Nov 5, 11:14 AMnewsvia finnhub

    Cardinal Health, Inc. (CAH) Q1 2027 Earnings Call Transcript

69. ❖Nov 5, 10:36 AMnewsvia finnhub

    S&P 500 Gap-Up and Gap-Down Stocks for Nov. 5, 2026

    S&P 500 stocks with the largest gap-up and gap-down moves on Nov. 5, 2026, including session changes for AppLovin, Bloom Energy, SanDisk, AMD, and others.

70. ✓Nov 5, 10:05 AMdecisionacted

    Agent 7 — Day Trader — decide: buy

    CAH is up 6.1% on strong earnings catalysts: Q1 EPS beat, revenue beat, and a raised outlook. This is a fundamental re-rating event with real institutional flow, not a speculative spike. The headlines confirm a solid beat-and-raise quarter, which typically sustains buying pressure as more participants react to the news throughout the session. With 340 minutes remaining (essentially most of the trading day), there is ample time for continuation. The cautious market reaction note in one headline suggests some hesitation, which may cap explosive upside but does not indicate active reversal pressure. The macro context (elevated DFF, banking sector reactive) is not directly relevant to healthcare distribution. No reversal pattern is evident — the move appears to be a clean gap-and-hold on earnings. Risk is bounded by the 1.5% stop. Assigning moderate continuation probability rather than high (≥0.7) because: (1) the 6.1% move is already large and some digestion is natural, (2) the 'cautious market reaction' headline suggests the initial spike may have absorbed near-term enthusiasm, and (3) no volume data is available to confirm sustained institutional accumulation. Overall, the balance of evidence favors continuation into the close.

71. ❖Nov 5, 9:02 AMnewsvia finnhub

    Cardinal Health Deepens Its Grip On The Buy Zone On Street-Beating Guidance

    Cardinal Health stock rose deeper into a buy zone Thursday on a solid third-quarter report and guidance hike.

72. ❖Nov 5, 8:59 AMnewsvia finnhub

    Cardinal Health Sees Healthy Demand, Despite Modest Commodity Pressure

    Cardinal Health tops Q1 2027 estimates, and raises guidance, as robust pharma sales offset petroleum headwinds in medical distribution.

73. ❖Nov 5, 8:30 AMnewsvia finnhub

    Compared to Estimates, Cardinal (CAH) Q1 Earnings: A Look at Key Metrics

    While the top- and bottom-line numbers for Cardinal (CAH) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

74. ❖Nov 5, 8:04 AMnewsvia finnhub

    Nasdaq Tumbles 4.5%; Cardinal Health Shares Gain After Upbeat Q1 Earnings

    U.S. stocks tumbled: Nasdaq -4.5%, S&P 500 -3.3%, Dow -2.5%. Cardinal Health rose on strong results; AppLovin surged 32%, while Veracyte fell 55%.

75. ❖Nov 5, 7:37 AMnewsvia finnhub

    Cardinal Health (NYSE:CAH) posts better-than-expected sales in Q3 CY2026

    Healthcare distributor and services company Cardinal Health (NYSE:CAH) announced better-than-expected revenue in calendar Q3 2026 (fiscal Q1 2027), with revenue up 5.5% year on year to $67.51 billion. Its non-GAAP profit of $3.26 per share was 10.9% above analysts’ consensus estimates.

76. ❖Nov 5, 7:27 AMnewsvia finnhub

    Cardinal Health (NYSE:CAH) Q1 EPS Beat Meets Cautious Market Reaction After Strong Rally

    Cardinal Health Q1 fiscal 2027 EPS beat consensus, revenue in line, outlook raised; shares slipped premarket after recent rally.

77. ❖Nov 5, 7:15 AMnewsvia finnhub

    Cardinal Health (CAH) Q1 Earnings and Revenues Top Estimates

    Cardinal (CAH) delivered earnings and revenue surprises of +11.64% and +0.83%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

78. ❖Nov 5, 6:52 AMnewsvia finnhub

    Cardinal: Fiscal Q1 Earnings Snapshot

    DUBLIN, Ohio (AP) — DUBLIN, Ohio (AP) — Cardinal Health Inc. (CAH) on Thursday reported fiscal first-quarter net income of $554 million.

79. ▢Nov 4, 7:00 PMjournal

    Agent 7 — Day Trader opened long 10 @ $277.91

80. ▣Nov 4, 7:00 PMjournalstop

    Agent 7 — Day Trader closed long 10 @ $273.63 (-$42.80)

    Long stop: close $273.63 ≤ stop $273.74

81. ▢Nov 4, 7:00 PMjournal

    Agent 7 — Day Trader opened long 11 @ $269.28

82. ▣Nov 4, 7:00 PMjournaltime_stop

    Agent 7 — Day Trader closed long 11 @ $269.47 (+$2.09)

    EOD forced close — day trader never carries overnight

83. ▣Nov 3, 7:00 PMjournaltarget

    Agent 5 — Dip Buyer (Evolving) closed long 3 @ $259.64 (+$82.88)

    Staged exit (1/2.0): close $259.64 ≥ target $258.30. Selling 3/6 sh, trailing remainder.

84. ?Oct 30, 9:35 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    CAH is up 2.54% today with no clearly attributable catalyst in the headlines (the McKesson article is a competitor piece and not directly CAH-specific). The move represents real institutional flow and momentum. With 370 minutes remaining (over 6 hours — likely this is early session), there is ample time for continuation. However, the macro backdrop (elevated mortgage rates at 2.3σ above trend) is largely irrelevant to CAH as a healthcare distributor, neither helping nor hurting. The absence of a specific CAH catalyst means we cannot assign high conviction to continuation — this could be sector rotation or sympathy trade with healthcare peers. No reversal signals are noted; the move appears to be holding rather than fading. Standard momentum logic applies: most meaningful intraday moves do not fully retrace on the day, and with a tight stop structure, the risk/reward favors a modest continuation bet. Probability set at 0.54 — weak continuation signal, no strong reason to fade, but no strong catalyst to push conviction higher.

85. !Oct 30, 9:35 AMsignalseverity 0.03

    Agent 7 — Day Trader — day_trade_skipped

    CAH is up 2.54% today with no clearly attributable catalyst in the headlines (the McKesson article is a competitor piece and not directly CAH-specific). The move represents real institutional flow and momentum. With 370 minutes remaining (over 6 hours — likely this is early session), there is ample time for continuation. However, the macro backdrop (elevated mortgage rates at 2.3σ above trend) is largely irrelevant to CAH as a healthcare distributor, neither helping nor hurting. The absence of a specific CAH catalyst means we cannot assign high conviction to continuation — this could be sector rotation or sympathy trade with healthcare peers. No reversal signals are noted; the move appears to be holding rather than fading. Standard momentum logic applies: most meaningful intraday moves do not fully retrace on the day, and with a tight stop structure, the risk/reward favors a modest continuation bet. Probability set at 0.54 — weak continuation signal, no strong reason to fade, but no strong catalyst to push conviction higher.

86. ?Oct 29, 10:01 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    CAH is up 1.54% today, a moderate move that suggests some real buying interest but not explosive conviction. There is no directly attributable catalyst for CAH specifically — the WST earnings headline is sector-adjacent (healthcare/medical supplies) but not a direct read-through. The macro context shows a slightly below-trend T10Y2Y spread, which is modestly supportive for defensive healthcare names like CAH. With 345 minutes remaining (essentially the full session still ahead), there is ample time for the move to extend, but the 1.54% magnitude is below the 2-5% threshold that would signal strong conviction flow. No reversal signals are noted. In the absence of a fade catalyst and with a defensive sector that is mildly supported by the current yield curve environment, the path of least resistance is continued drift higher or consolidation near current levels. Assigning a modest continuation probability above the 0.5 threshold given the supportive but unremarkable setup.

87. !Oct 29, 10:01 AMsignalseverity 0.02

    Agent 7 — Day Trader — day_trade_skipped

    CAH is up 1.54% today, a moderate move that suggests some real buying interest but not explosive conviction. There is no directly attributable catalyst for CAH specifically — the WST earnings headline is sector-adjacent (healthcare/medical supplies) but not a direct read-through. The macro context shows a slightly below-trend T10Y2Y spread, which is modestly supportive for defensive healthcare names like CAH. With 345 minutes remaining (essentially the full session still ahead), there is ample time for the move to extend, but the 1.54% magnitude is below the 2-5% threshold that would signal strong conviction flow. No reversal signals are noted. In the absence of a fade catalyst and with a defensive sector that is mildly supported by the current yield curve environment, the path of least resistance is continued drift higher or consolidation near current levels. Assigning a modest continuation probability above the 0.5 threshold given the supportive but unremarkable setup.

88. ▣Oct 14, 8:00 PMjournaltarget

    Agent 8 — Dip Buyer (Peer-Aware) closed long 3 @ $251.41 (+$66.58)

    Staged exit (1/2.0): close $251.41 ≥ target $249.29. Selling 3/6 sh, trailing remainder.

89. ✓Oct 14, 4:00 PMdecisionacted

    Agent 5 — Dip Buyer (Evolving) — pyramid

    Pyramid add-on fired at +10.33% unrealized. Added 2 sh @ $247.46 ($494.92). Position now 6 sh @ weighted avg $232.01.

90. ✓Oct 14, 11:16 AMdecisionacted

    Agent 8 — Dip Buyer (Peer-Aware) — pyramid

    Pyramid add-on fired at +10.05% unrealized. Added 2 sh @ $244.07 ($488.14). Position now 6 sh @ weighted avg $229.22.

91. ?Oct 14, 10:55 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    CAH is up 1.61% today, a modest but real move suggesting some institutional buying interest. The sole headline is a minor advisory board appointment with no material price impact. The macro context shows 5Y5Y inflation forwards running 1.5σ above trend, which creates mild headwinds for rate-sensitive sectors broadly, though healthcare distributors like CAH are not highly rate-sensitive in their core business. With 290 minutes remaining (roughly 4 hours 50 minutes to the 3:45 PM cutoff), there is ample time for continuation if buying pressure persists. However, the move magnitude is relatively modest at 1.61%, below the threshold where strong institutional conviction is clearly evident, and there is no clear catalyst driving the move. No reversal or fade pattern is indicated. On balance, the default edge toward continuation applies given time remaining, bounded downside, and no clear fade signal, but conviction is low — assigning a slight edge to continuation without strong supporting evidence.

92. !Oct 14, 10:55 AMsignalseverity 0.02

    Agent 7 — Day Trader — day_trade_skipped

    CAH is up 1.61% today, a modest but real move suggesting some institutional buying interest. The sole headline is a minor advisory board appointment with no material price impact. The macro context shows 5Y5Y inflation forwards running 1.5σ above trend, which creates mild headwinds for rate-sensitive sectors broadly, though healthcare distributors like CAH are not highly rate-sensitive in their core business. With 290 minutes remaining (roughly 4 hours 50 minutes to the 3:45 PM cutoff), there is ample time for continuation if buying pressure persists. However, the move magnitude is relatively modest at 1.61%, below the threshold where strong institutional conviction is clearly evident, and there is no clear catalyst driving the move. No reversal or fade pattern is indicated. On balance, the default edge toward continuation applies given time remaining, bounded downside, and no clear fade signal, but conviction is low — assigning a slight edge to continuation without strong supporting evidence.

93. ?Oct 8, 1:36 PMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    CAH is up 1.85% today with no attributable headline, suggesting this is likely flow-driven rather than news-driven. Cardinal Health is a healthcare distributor/services company with minimal direct sensitivity to mortgage rates or homebuilder/REIT macro context — so the elevated MORTGAGE30US reading at 3.8σ above trend is largely irrelevant to CAH's business fundamentals and does not provide a meaningful headwind or tailwind. The move of ~1.85% is real but below the 2-5% threshold that would signal strong conviction. With 130 minutes remaining there is reasonable time for continuation, but without a clear catalyst or sector tailwind, the move may simply consolidate or drift sideways rather than extend meaningfully. No reversal signals are evident from the available data. Overall, this is a mild momentum setup with no strong reason to expect a fade, but also no clear continuation pressure — probability sits just above the 0.5 threshold.

94. !Oct 8, 1:36 PMsignalseverity 0.02

    Agent 7 — Day Trader — day_trade_skipped

    CAH is up 1.85% today with no attributable headline, suggesting this is likely flow-driven rather than news-driven. Cardinal Health is a healthcare distributor/services company with minimal direct sensitivity to mortgage rates or homebuilder/REIT macro context — so the elevated MORTGAGE30US reading at 3.8σ above trend is largely irrelevant to CAH's business fundamentals and does not provide a meaningful headwind or tailwind. The move of ~1.85% is real but below the 2-5% threshold that would signal strong conviction. With 130 minutes remaining there is reasonable time for continuation, but without a clear catalyst or sector tailwind, the move may simply consolidate or drift sideways rather than extend meaningfully. No reversal signals are evident from the available data. Overall, this is a mild momentum setup with no strong reason to expect a fade, but also no clear continuation pressure — probability sits just above the 0.5 threshold.

95. ?Oct 5, 11:05 AMdecisionconsidered

    Agent 7 — Day Trader — decide: skip

    CAH is up 1.51% today with 280 minutes remaining — a meaningful move but not yet in the 2-5% range that signals strong institutional conviction. No headlines are available to explain the move, which is common and not disqualifying, but limits our ability to assess whether a catalyst has further legs. The macro context shows the 5-year forward inflation rate elevated at 1.8σ above trend, which is modestly negative for rate-sensitive sectors broadly; however, CAH (Cardinal Health) is a healthcare distributor, which is relatively defensive and less rate-sensitive than pure financials or utilities. The elevated inflation expectation environment doesn't create a clear headwind here. With 280 minutes remaining, there is ample time for the move to extend. The 1.51% gain is real flow but modest — not a blowout that would scream 'fading into close.' No reversal signal or volume concern is identifiable from the data provided. Overall, a mild momentum continuation bias is appropriate, but the absence of a clear catalyst and the macro backdrop being neutral-to-slightly-negative for rate-sensitive names keeps conviction modest.

96. !Oct 5, 11:05 AMsignalseverity 0.02

    Agent 7 — Day Trader — day_trade_skipped

    CAH is up 1.51% today with 280 minutes remaining — a meaningful move but not yet in the 2-5% range that signals strong institutional conviction. No headlines are available to explain the move, which is common and not disqualifying, but limits our ability to assess whether a catalyst has further legs. The macro context shows the 5-year forward inflation rate elevated at 1.8σ above trend, which is modestly negative for rate-sensitive sectors broadly; however, CAH (Cardinal Health) is a healthcare distributor, which is relatively defensive and less rate-sensitive than pure financials or utilities. The elevated inflation expectation environment doesn't create a clear headwind here. With 280 minutes remaining, there is ample time for the move to extend. The 1.51% gain is real flow but modest — not a blowout that would scream 'fading into close.' No reversal signal or volume concern is identifiable from the data provided. Overall, a mild momentum continuation bias is appropriate, but the absence of a clear catalyst and the macro backdrop being neutral-to-slightly-negative for rate-sensitive names keeps conviction modest.

97. ✓Oct 1, 11:10 AMdecisionacted

    Agent 7 — Day Trader — decide: buy

    CAH is up 2.57% on a clear, material catalyst: a confirmed binding letter of intent to extend its pharmaceutical distribution agreement with CVS Health through 2032. This is a high-quality, contract-security news event that removes uncertainty from a major revenue stream. The news was confirmed mid-morning (10:50 AM), with a follow-up headline at 12:41 PM confirming the extension — suggesting the story is still being absorbed and disseminated by the market. With 275 minutes remaining until the 3:45 PM cutoff, there is ample time for additional institutional flow to follow the initial move. Sector context (Medical/Dental Supply stocks noted as having improving prospects) provides a mild tailwind. The macro concern — 5Y forward inflation running 2.0σ above trend — is a rate-sensitive headwind, but CAH is a defensive, low-beta healthcare distributor with relatively low interest rate sensitivity compared to pure rate-sensitive sectors. The contract extension story is idiosyncratic and positive enough to insulate from macro drag. No reversal signals are evident in the available data. The move appears to have legs into the close, though not a runaway — pricing at 0.68 to reflect a solid but not exceptional setup.

98. ▢Sep 30, 8:00 PMjournal

    Agent 7 — Day Trader opened long 12 @ $228.21

99. ▣Sep 30, 8:00 PMjournaltime_stop

    Agent 7 — Day Trader closed long 12 @ $229.91 (+$20.40)

    EOD forced close — day trader never carries overnight

100. ?Sep 24, 6:21 PMdecisionconsidered

     Agent 20 — SIR Price/Volume — skip

     [distribution] The 20-day PV path traces a clear down-and-right drift from the $248.61 peak on 2026-09-03 to today's $222.62, with dominant volume on down-days throughout the descent. The most damning segment is 2026-09-17 through 2026-09-18: price fell from $232.54 to $225.38 on sharply expanding volume (2.3M and 4.1M respectively, with 4.1M representing ~2.4× the 20-day ADV of 1.7M) — a classic distribution signature. Today's single up-day on 3.0M (z-score +1.85) is insufficiently sustained to reverse the pattern; the path has produced seven of the last nine sessions as DOWN days, and up-day volume has been consistently lighter (e.g., 1.2M on 2026-09-21, 1.2M on 2026-09-23) relative to down-day volume, confirming sellers remain in control. Risks: A macro regime check is warranted: if the broad index is in a confirmed bull regime with VIX below 20, the distribution label requires multi-session confirmation and the asymmetric burden-of-proof rule applies — in that case, today's single up-bar on elevated volume could instead signal a no_pattern read pending follow-through. Additionally, the elevated 5-year inflation breakeven (T5YIFR at 2.36, 2.0σ above trend) adds macro headwind for rate-sensitive Health Care names, which supports the bearish read but could reverse quickly on a dovish Fed catalyst.

101. ?Sep 24, 1:55 PMdecisionconsidered

     Agent 7 — Day Trader — decide: skip

     CAH is up 1.71% with 110 minutes remaining, a moderate but meaningful intraday move suggesting real institutional flow. No news catalyst is identifiable, but absence of news does not negate momentum. The macro context shows the 5-year forward inflation rate (T5YIFR) is 2.0σ above trend, which broadly pressures rate-sensitive sectors. CAH (healthcare/pharma distribution) is not a classic rate-sensitive name, so this macro headwind is muted rather than direct. With no reversal signals noted and a moderate move that hasn't yet hit an extended range (not in the 2-5% zone where exhaustion is more likely), there is modest continuation bias. Time remaining is adequate for further follow-through. However, the lack of a clear catalyst, absence of volume data to confirm conviction, and a modestly unfavorable macro backdrop (elevated inflation expectations can pressure broader risk) keep this in the low-confidence continuation bucket. Assigning a slight lean toward continuation given the asymmetric risk structure of the system.

102. !Sep 24, 1:55 PMsignalseverity 0.02

     Agent 7 — Day Trader — day_trade_skipped

     CAH is up 1.71% with 110 minutes remaining, a moderate but meaningful intraday move suggesting real institutional flow. No news catalyst is identifiable, but absence of news does not negate momentum. The macro context shows the 5-year forward inflation rate (T5YIFR) is 2.0σ above trend, which broadly pressures rate-sensitive sectors. CAH (healthcare/pharma distribution) is not a classic rate-sensitive name, so this macro headwind is muted rather than direct. With no reversal signals noted and a moderate move that hasn't yet hit an extended range (not in the 2-5% zone where exhaustion is more likely), there is modest continuation bias. Time remaining is adequate for further follow-through. However, the lack of a clear catalyst, absence of volume data to confirm conviction, and a modestly unfavorable macro backdrop (elevated inflation expectations can pressure broader risk) keep this in the low-confidence continuation bucket. Assigning a slight lean toward continuation given the asymmetric risk structure of the system.

103. ✓Sep 24, 7:04 AMdecisionacted

     Agent 8 — Dip Buyer (Peer-Aware) — decide: buy

     CAH (Cardinal Health) is a large-cap healthcare distributor with a historically stable business model, and the 11.2% dip from its 30-day high lacks any identifiable fundamental catalyst — no negative news headlines, no insider selling, and no confirmed guidance cut or earnings miss in the recent 10-K filing period. The options flow shows a favorable put/call ratio of 0.66 with put volume notably below normal (z=-1.64), suggesting the market is not aggressively hedging downside, while call volume is near average. Healthcare sector (XLV) shows modest 30-day outperformance vs. SPY (+0.83pts), suggesting the drop is idiosyncratic rather than sector-driven, warranting some caution but also implying a potential mean-reversion opportunity.

104. ▢Sep 23, 8:00 PMjournal

     Agent 8 — Dip Buyer (Peer-Aware) opened long 3 @ $229.22

105. ?Sep 23, 4:20 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

106. !Sep 23, 4:20 PMsignalseverity 0.11

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

107. ?Sep 23, 3:20 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

108. !Sep 23, 3:20 PMsignalseverity 0.11

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

109. ?Sep 23, 2:21 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

110. !Sep 23, 2:21 PMsignalseverity 0.11

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

111. ?Sep 23, 1:20 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

112. !Sep 23, 1:20 PMsignalseverity 0.10

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

113. ?Sep 23, 12:20 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

114. !Sep 23, 12:20 PMsignalseverity 0.10

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

115. ?Sep 23, 11:20 AMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

116. !Sep 23, 11:20 AMsignalseverity 0.10

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

117. ?Sep 23, 7:00 AMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

118. !Sep 23, 7:00 AMsignalseverity 0.14

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

119. ?Sep 22, 4:21 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

120. !Sep 22, 4:21 PMsignalseverity 0.14

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

121. ?Sep 22, 3:20 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

122. !Sep 22, 3:20 PMsignalseverity 0.14

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

123. ?Sep 22, 2:21 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

124. !Sep 22, 2:21 PMsignalseverity 0.14

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

125. ?Sep 22, 1:20 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

126. !Sep 22, 1:20 PMsignalseverity 0.12

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

127. ?Sep 22, 12:21 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

128. !Sep 22, 12:21 PMsignalseverity 0.12

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

129. ?Sep 22, 11:20 AMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

130. !Sep 22, 11:20 AMsignalseverity 0.12

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

131. ?Sep 22, 10:21 AMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

132. !Sep 22, 10:21 AMsignalseverity 0.12

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

133. ?Sep 22, 7:00 AMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

134. !Sep 22, 7:00 AMsignalseverity 0.13

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

135. ?Sep 21, 4:21 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

136. !Sep 21, 4:21 PMsignalseverity 0.13

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

137. ?Sep 21, 3:20 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

138. !Sep 21, 3:20 PMsignalseverity 0.12

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

139. ?Sep 21, 2:20 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

140. !Sep 21, 2:20 PMsignalseverity 0.12

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

141. ?Sep 21, 1:20 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

142. !Sep 21, 1:20 PMsignalseverity 0.12

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

143. ?Sep 21, 12:21 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

144. !Sep 21, 12:21 PMsignalseverity 0.13

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

145. ?Sep 21, 11:21 AMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

146. !Sep 21, 11:21 AMsignalseverity 0.13

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

147. ?Sep 21, 10:20 AMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

148. !Sep 21, 10:20 AMsignalseverity 0.13

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

149. ✓Sep 21, 10:20 AMdecisionacted

     Agent 5 — Dip Buyer (Evolving) — decide: buy

     [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] CAH (Cardinal Health) is a large-cap defensive healthcare distributor in the #2-ranked sector by 30-day relative strength, with XLV outperforming SPY by +5.74pts over 30 days and positive sector flow today — suggesting the 12.4% drop is largely idiosyncratic rather than sector-driven. No fundamental deterioration is evident from the filings (no guidance cut, going-concern, or covenant breach language is flagged), and there are no insider sales. The base rate for a fundamentally unimpaired S&P 500 name recovering a ~12% dip within 90 days is ~55-60%, which anchors the probability estimate.

150. ?Sep 21, 7:00 AMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

151. !Sep 21, 7:00 AMsignalseverity 0.13

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

152. ?Sep 21, 7:00 AMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: buy

     [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] CAH (Cardinal Health) is a large-cap defensive healthcare distributor in the #2-ranked sector by 30-day relative strength, with XLV outperforming SPY by +5.74pts over 30 days and positive sector flow today — suggesting the 12.4% drop is largely idiosyncratic rather than sector-driven. No fundamental deterioration is evident from the filings (no guidance cut, going-concern, or covenant breach language is flagged), and there are no insider sales. The base rate for a fundamentally unimpaired S&P 500 name recovering a ~12% dip within 90 days is ~55-60%, which anchors the probability estimate.

153. ▢Sep 20, 8:00 PMjournal

     Agent 5 — Dip Buyer (Evolving) opened long 3 @ $232.01

154. ?Sep 18, 4:20 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: buy

     [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] CAH (Cardinal Health) is a large-cap defensive healthcare distributor in the #2-ranked sector by 30-day relative strength, with XLV outperforming SPY by +5.74pts over 30 days and positive sector flow today — suggesting the 12.4% drop is largely idiosyncratic rather than sector-driven. No fundamental deterioration is evident from the filings (no guidance cut, going-concern, or covenant breach language is flagged), and there are no insider sales. The base rate for a fundamentally unimpaired S&P 500 name recovering a ~12% dip within 90 days is ~55-60%, which anchors the probability estimate.

155. ?Sep 18, 4:20 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

156. !Sep 18, 4:20 PMsignalseverity 0.13

     Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

157. ?Sep 18, 3:20 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: buy

     [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] CAH (Cardinal Health) is a large-cap defensive healthcare distributor in the #2-ranked sector by 30-day relative strength, with XLV outperforming SPY by +5.74pts over 30 days and positive sector flow today — suggesting the 12.4% drop is largely idiosyncratic rather than sector-driven. No fundamental deterioration is evident from the filings (no guidance cut, going-concern, or covenant breach language is flagged), and there are no insider sales. The base rate for a fundamentally unimpaired S&P 500 name recovering a ~12% dip within 90 days is ~55-60%, which anchors the probability estimate.

158. ?Sep 18, 3:20 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

159. ?Sep 18, 2:20 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: buy

     [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] CAH (Cardinal Health) is a large-cap defensive healthcare distributor in the #2-ranked sector by 30-day relative strength, with XLV outperforming SPY by +5.74pts over 30 days and positive sector flow today — suggesting the 12.4% drop is largely idiosyncratic rather than sector-driven. No fundamental deterioration is evident from the filings (no guidance cut, going-concern, or covenant breach language is flagged), and there are no insider sales. The base rate for a fundamentally unimpaired S&P 500 name recovering a ~12% dip within 90 days is ~55-60%, which anchors the probability estimate.

160. ?Sep 18, 2:20 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

161. ?Sep 18, 1:20 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: buy

     [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] CAH (Cardinal Health) is a large-cap defensive healthcare distributor in the #2-ranked sector by 30-day relative strength, with XLV outperforming SPY by +5.74pts over 30 days and positive sector flow today — suggesting the 12.4% drop is largely idiosyncratic rather than sector-driven. No fundamental deterioration is evident from the filings (no guidance cut, going-concern, or covenant breach language is flagged), and there are no insider sales. The base rate for a fundamentally unimpaired S&P 500 name recovering a ~12% dip within 90 days is ~55-60%, which anchors the probability estimate.

162. ?Sep 18, 1:20 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

163. ?Sep 18, 12:21 PMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: buy

     [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] CAH (Cardinal Health) is a large-cap defensive healthcare distributor in the #2-ranked sector by 30-day relative strength, with XLV outperforming SPY by +5.74pts over 30 days and positive sector flow today — suggesting the 12.4% drop is largely idiosyncratic rather than sector-driven. No fundamental deterioration is evident from the filings (no guidance cut, going-concern, or covenant breach language is flagged), and there are no insider sales. The base rate for a fundamentally unimpaired S&P 500 name recovering a ~12% dip within 90 days is ~55-60%, which anchors the probability estimate.

164. ?Sep 18, 12:21 PMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

165. ?Sep 18, 11:20 AMdecisionconsidered

     Agent 5 — Dip Buyer (Evolving) — decide: buy

     [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] CAH (Cardinal Health) is a large-cap defensive healthcare distributor in the #2-ranked sector by 30-day relative strength, with XLV outperforming SPY by +5.74pts over 30 days and positive sector flow today — suggesting the 12.4% drop is largely idiosyncratic rather than sector-driven. No fundamental deterioration is evident from the filings (no guidance cut, going-concern, or covenant breach language is flagged), and there are no insider sales. The base rate for a fundamentally unimpaired S&P 500 name recovering a ~12% dip within 90 days is ~55-60%, which anchors the probability estimate.

166. ?Sep 18, 11:20 AMdecisionconsidered

     Agent 8 — Dip Buyer (Peer-Aware) — decide: skip

     CAH is a fundamentally sound healthcare distributor with a 12.4% dip from its 30-day high, now trading at $226.32 against a prior stop-out at $220.48 — the stock has already recovered well above the prior entry. The Health Care sector is showing strong relative strength (rank 2/11, +5.74pts vs SPY over 30 days), suggesting the dip is idiosyncratic rather than sector-driven, which warrants investigation into the cause. However, there are no news headlines, no insider buying, muted/slightly bearish options flow (P/C ratio 1.32), and the 10-K metrics are empty — leaving the drop unexplained and the recovery thesis without a grounding catalyst. Earnings are 41 days away, reducing binary risk but not providing a near-term catalyst either. The macro backdrop features an elevated 10Y yield of 5.00% and rates that are a structural headwind for defensives.

167. ▢Sep 16, 8:00 PMjournal

     Agent 4 — Dip Buyer (Frozen) opened long 4 @ $226.34

168. ▣Sep 10, 8:00 PMjournaltime_stop

     Agent 20 — SIR Price/Volume closed long 9 @ $234.57 (+$164.43)

     Time stop: held 92 ≥ 90 days

169. ▣Aug 23, 8:00 PMjournalstop

     Agent 7 — Day Trader closed long 12 @ $231.00 (-$170.16)

     Long stop: close $231.00 ≤ stop $241.50

170. ▢Aug 10, 8:00 PMjournal

     Agent 7 — Day Trader opened long 12 @ $245.18

171. ▣Jul 21, 8:00 PMjournaltarget

     Agent 8 — Dip Buyer (Peer-Aware) closed long 5 @ $220.48 (+$96.68)

     Trailing stop on remainder: close $220.48 ≤ floor $222.93 (peak $239.71 × 0.93; floor at entry $201.14)

172. ▣Jun 14, 8:00 PMjournalmanual

     Agent 5 — Dip Buyer (Evolving) closed long 1 @ $222.47 (+$28.09)

     Staged exit (1/2.0): close $223.85 ≥ target $217.77. Selling 1/2 sh, trailing remainder.

173. ▣Jun 14, 8:00 PMjournaltarget

     Agent 5 — Dip Buyer (Evolving) closed long 1 @ $226.38 (+$32.00)

     Target hit (partial-rounded-to-full): close $226.38 ≥ target $217.77

174. ▣Jun 11, 8:00 PMjournalmanual

     Agent 5 — Dip Buyer (Evolving) closed long 1 @ $217.49 (+$23.11)

     Staged exit (1/2.0): close $221.16 ≥ target $217.77. Selling 1/3 sh, trailing remainder.

175. ▣Jun 10, 8:00 PMjournaltarget

     Agent 8 — Dip Buyer (Peer-Aware) closed long 5 @ $221.16 (+$100.08)

     Staged exit (1/2.0): close $221.16 ≥ target $217.77. Selling 5/10 sh, trailing remainder.

176. ▣Jun 10, 8:00 PMjournaltarget

     Agent 5 — Dip Buyer (Evolving) closed long 3 @ $221.16 (+$80.34)

     Staged exit (1/2.0): close $221.16 ≥ target $217.77. Selling 3/6 sh, trailing remainder.

177. ▢Jun 10, 8:00 PMjournal

     Agent 20 — SIR Price/Volume opened long 9 @ $216.30

178. ▣May 28, 8:00 PMjournalstop

     options_momentum closed long 100 @ $5.35 (-$260.20)

     Stop: premium $5.35 ≤ trailing floor $6.38 (peak $8.51 × 0.75)

179. ▢May 19, 8:00 PMjournal

     options_momentum opened long 100 @ $7.95

180. ▢May 17, 8:00 PMjournal

     Agent 8 — Dip Buyer (Peer-Aware) opened long 5 @ $201.14

181. ▢May 17, 8:00 PMjournal

     Agent 8 — Dip Buyer (Peer-Aware) opened long 5 @ $201.14

182. ▢May 14, 8:00 PMjournal

     Agent 7 — Day Trader opened long 10 @ $194.38

183. ▣May 14, 8:00 PMjournaltime_stop

     Agent 7 — Day Trader closed long 10 @ $196.08 (+$17.00)

     EOD forced close — day trader never carries overnight

184. ▢May 14, 8:00 PMjournal

     Agent 5 — Dip Buyer (Evolving) opened long 3 @ $194.38

185. ▢May 14, 8:00 PMjournal

     Agent 5 — Dip Buyer (Evolving) opened long 1 @ $194.38

186. ▢May 14, 8:00 PMjournal

     Agent 5 — Dip Buyer (Evolving) opened long 1 @ $194.38

187. ▢May 14, 8:00 PMjournal

     Agent 5 — Dip Buyer (Evolving) opened long 1 @ $194.38